JOHN MENDLEIN

CIK 1238362 · CEO and Director · last filed 2025-05-30

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.25M

Companies

5

Total Filings

40

Lifetime Open-Market Net

$42.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
FATE Director 311,231 $2.06 $641.1K -$338.1K 16 2025-05-30
Omega Therapeutics, Inc. (OMGA) Delisted Director $0.14 $0 3 2024-06-21
LIFE CEO and Director 615,382 $15.61 $9.61M $380.6K 16 2019-05-10
EDIT Director $2.50 $0 2 2017-06-19
Monogram Biosciences, Inc. (MGRM) Delisted Director $6.00 $0 3 2009-01-21

Recent Filings · Page 2 of 4

40 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-03-11 FATE Mixed -$1.05M EDGAR
2021-06-04 FATE Grant (A) +2,681 $0 EDGAR
2020-05-05 FATE Grant (A) $0 EDGAR
2019-05-10 LIFE Grant (A) $0 EDGAR
2019-05-07 FATE Grant (A) $0 EDGAR
2018-12-26 LIFE Buy (P) +245,000 $103.2K EDGAR
2018-05-17 LIFE Grant (A) $0 EDGAR
2018-05-04 FATE Grant (A) $0 EDGAR
2018-01-02 LIFE Grant (A) $0 EDGAR
2017-09-05 LIFE Buy (P) +37,736 $100.0K EDGAR
Showing 1120 of 40
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.